In sorafenib-resistant HCC, abnormal expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes chemoresistance by stimulating AKT-S473 phosphorylation. This evidence concerns the gene PCSK9 and hepatocellular carcinoma.